Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 44 entries
Sorted by: Best Match Show Resources per page
Clinical and angiographic risk assessment in patients with left main stem lesions

stem intervention research

Garg S, Kappetein AP, Stone GW.
GSID: XBNrTBps5oUJ
S Garg, GW Stone, AP Kappetein, JF Sabik… - JACC: Cardiovascular …, 2010 - jacc.org

Percutaneous coronary intervention of unprotected left main stem lesions has been shown to be a suitable alternative to cardiac surgery in selected patients, emphasizing the need for appropriate risk stratification prior to selection of revascularization modality. Several risk models...

Cite
Garg, S., Stone, G. W., Kappetein, A. P., Sabik, J. F., Simonton, C., & Serruys, P. W. (2010). Clinical and angiographic risk assessment in patients with left main stem lesions. JACC: Cardiovascular Interventions, 3(9), 891-901.
Garg, Scot, et al. "Clinical and angiographic risk assessment in patients with left main stem lesions." JACC: Cardiovascular Interventions 3.9 (2010): 891-901.
Copy Download .nbib Format: MLA
Drug-eluting stent-supported percutaneous coronary intervention in high risk patients refused cardiac surgery.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Michels M, Caliskan K, Ong AT, McFadden EP, Kappetein AP, van Domburg RT, Serruys PW.
PMID: 19758900
EuroIntervention. 2005 Aug;1(2):181-5.

AIMS: Randomized trials of drug-eluting stents (DES) have demonstrated their ability to improve clinical outcome in relatively simple lesion/patient subsets. Their potential in patients for whom the risk of coronary bypass grafting is judged prohibitive, remains largely unexplored. To...

Cite
Michels M, Caliskan K, Ong AT, et al. Drug-eluting stent-supported percutaneous coronary intervention in high risk patients refused cardiac surgery. EuroIntervention. 2005;1(2):181-5
Michels, M., Caliskan, K., Ong, A. T., McFadden, E. P., Kappetein, A. P., van Domburg, R. T., & Serruys, P. W. (2005). Drug-eluting stent-supported percutaneous coronary intervention in high risk patients refused cardiac surgery. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 1(2), 181-5.
Michels, Michelle, et al. "Drug-eluting stent-supported percutaneous coronary intervention in high risk patients refused cardiac surgery." EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology vol. 1,2 (2005): 181-5.
Michels M, Caliskan K, Ong AT, McFadden EP, Kappetein AP, van Domburg RT, Serruys PW. Drug-eluting stent-supported percutaneous coronary intervention in high risk patients refused cardiac surgery. EuroIntervention. 2005 Aug;1(2):181-5. PMID: 19758900.
Copy Download .nbib Format: NLM
Does the type of biological valve affect patient outcome?.

Interactive cardiovascular and thoracic surgery

Kappetein AP, Takkenberg JJ, Puvimanasinghe JP, Jamieson WR, Eijkemans M, Bogers AJ.
PMID: 17670601
Interact Cardiovasc Thorac Surg. 2006 Aug;5(4):398-402. doi: 10.1510/icvts.2005.122382. Epub 2006 May 05.

Patient background mortality and excess mortality related to aortic valve disease may play a greater role than implanted valve type in explaining the observed survival differences after aortic valve replacement. This study attempts to identify the differences between the...

Cite
Kappetein AP, Takkenberg JJ, Puvimanasinghe JP, et al. Does the type of biological valve affect patient outcome?. Interact Cardiovasc Thorac Surg. 2006;5(4):398-402doi: 10.1510/icvts.2005.122382.
Kappetein, A. P., Takkenberg, J. J., Puvimanasinghe, J. P., Jamieson, W. R., Eijkemans, M., & Bogers, A. J. (2006). Does the type of biological valve affect patient outcome?. Interactive cardiovascular and thoracic surgery, 5(4), 398-402. https://doi.org/10.1510/icvts.2005.122382
Kappetein, A Pieter, et al. "Does the type of biological valve affect patient outcome?." Interactive cardiovascular and thoracic surgery vol. 5,4 (2006): 398-402. doi: https://doi.org/10.1510/icvts.2005.122382
Kappetein AP, Takkenberg JJ, Puvimanasinghe JP, Jamieson WR, Eijkemans M, Bogers AJ. Does the type of biological valve affect patient outcome?. Interact Cardiovasc Thorac Surg. 2006 Aug;5(4):398-402. doi: 10.1510/icvts.2005.122382. Epub 2006 May 05. PMID: 17670601.
Copy Download .nbib Format: NLM
Invited commentary.

The Annals of thoracic surgery

Kappetein AP, Osnabrugge RL.
PMID: 24484795
Ann Thorac Surg. 2014 Feb;97(2):528-9. doi: 10.1016/j.athoracsur.2013.12.004.

No abstract available.

Cite
Kappetein AP, Osnabrugge RL. Invited commentary. Ann Thorac Surg. 2014;97(2):528-9doi: 10.1016/j.athoracsur.2013.12.004.
Kappetein, A. P., & Osnabrugge, R. L. (2014). Invited commentary. The Annals of thoracic surgery, 97(2), 528-9. https://doi.org/10.1016/j.athoracsur.2013.12.004
Kappetein, Arie Pieter, and Osnabrugge, Ruben L J. "Invited commentary." The Annals of thoracic surgery vol. 97,2 (2014): 528-9. doi: https://doi.org/10.1016/j.athoracsur.2013.12.004
Kappetein AP, Osnabrugge RL. Invited commentary. Ann Thorac Surg. 2014 Feb;97(2):528-9. doi: 10.1016/j.athoracsur.2013.12.004. PMID: 24484795.
Copy Download .nbib Format: NLM
Off-pump or on-pump coronary-artery bypass grafting.

The New England journal of medicine

Head SJ, Kappetein AP.
PMID: 22873548
N Engl J Med. 2012 Aug 09;367(6):577-8; author reply 578. doi: 10.1056/NEJMc1205991.

No abstract available.

Cite
Head SJ, Kappetein AP. Off-pump or on-pump coronary-artery bypass grafting. N Engl J Med. 2012;367(6):577-8; author reply 578doi: 10.1056/NEJMc1205991.
Head, S. J., & Kappetein, A. P. (2012). Off-pump or on-pump coronary-artery bypass grafting. The New England journal of medicine, 367(6), 577-8; author reply 578. https://doi.org/10.1056/NEJMc1205991
Head, Stuart J, and Kappetein, A Pieter. "Off-pump or on-pump coronary-artery bypass grafting." The New England journal of medicine vol. 367,6 (2012): 577-8; author reply 578. doi: https://doi.org/10.1056/NEJMc1205991
Head SJ, Kappetein AP. Off-pump or on-pump coronary-artery bypass grafting. N Engl J Med. 2012 Aug 09;367(6):577-8; author reply 578. doi: 10.1056/NEJMc1205991. PMID: 22873548.
Copy Download .nbib Format: NLM
10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy Calcification.

JACC. Cardiovascular interventions

Kawashima H, Serruys PW, Hara H, Ono M, Gao C, Wang R, Garg S, Sharif F, de Winter RJ, Mack MJ, Holmes DR, Morice MC, Kappetein AP, Thuijs DJFM, Milojevic M, Noack T, Mohr FW, Davierwala PM, Onuma Y.
PMID: 34973904
JACC Cardiovasc Interv. 2021 Dec 20; doi: 10.1016/j.jcin.2021.10.026. Epub 2021 Dec 20.

OBJECTIVES: The aim of this study was to assess 10-year all-cause mortality in patients with heavily calcified lesions (HCLs) undergoing percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).BACKGROUND: Limited data are available on very long term outcomes...

Cite
Kawashima H, Serruys PW, Hara H, et al. 10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy Calcification. JACC Cardiovasc Interv. 2021;doi: 10.1016/j.jcin.2021.10.026.
Kawashima, H., Serruys, P. W., Hara, H., Ono, M., Gao, C., Wang, R., Garg, S., Sharif, F., de Winter, R. J., Mack, M. J., Holmes, D. R., Morice, M. C., Kappetein, A. P., Thuijs, D. J. F. M., Milojevic, M., Noack, T., Mohr, F. W., Davierwala, P. M., Onuma, Y. (2021). 10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy Calcification. JACC. Cardiovascular interventions, . https://doi.org/10.1016/j.jcin.2021.10.026
Kawashima, Hideyuki, et al. "10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy Calcification." JACC. Cardiovascular interventions vol. (2021). doi: https://doi.org/10.1016/j.jcin.2021.10.026
Kawashima H, Serruys PW, Hara H, Ono M, Gao C, Wang R, Garg S, Sharif F, de Winter RJ, Mack MJ, Holmes DR, Morice MC, Kappetein AP, Thuijs DJFM, Milojevic M, Noack T, Mohr FW, Davierwala PM, Onuma Y. 10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy Calcification. JACC Cardiovasc Interv. 2021 Dec 20; doi: 10.1016/j.jcin.2021.10.026. Epub 2021 Dec 20. PMID: 34973904.
Copy Download .nbib Format: NLM
Long-term survival after coronary bypass surgery with multiple versus single arterial grafts.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

Thuijs DJFM, Davierwala P, Milojevic M, Deo SV, Noack T, Kappetein AP, Serruys PW, Mohr FW, Morice MC, Mack MJ, Ståhle LEGE, Verberkmoes NJ, Holmes DR, Head SJ.
PMID: 34618017
Eur J Cardiothorac Surg. 2021 Oct 07; doi: 10.1093/ejcts/ezab392. Epub 2021 Oct 07.

OBJECTIVES: This study sought to evaluate the long-term differences in survival between multiple arterial grafts (MAG) and single arterial grafts (SAG) in patients who underwent coronary artery bypass grafting (CABG) in the SYNTAX study.METHODS: The present analysis included the...

Cite
Thuijs DJFM, Davierwala P, Milojevic M, et al. Long-term survival after coronary bypass surgery with multiple versus single arterial grafts. Eur J Cardiothorac Surg. 2021;doi: 10.1093/ejcts/ezab392.
Thuijs, D. J. F. M., Davierwala, P., Milojevic, M., Deo, S. V., Noack, T., Kappetein, A. P., Serruys, P. W., Mohr, F. W., Morice, M. C., Mack, M. J., Ståhle, L. E. G. E., Verberkmoes, N. J., Holmes, D. R., Head, S. J. (2021). Long-term survival after coronary bypass surgery with multiple versus single arterial grafts. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, . https://doi.org/10.1093/ejcts/ezab392
Thuijs, Daniel J F M, et al. "Long-term survival after coronary bypass surgery with multiple versus single arterial grafts." European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery vol. (2021). doi: https://doi.org/10.1093/ejcts/ezab392
Thuijs DJFM, Davierwala P, Milojevic M, Deo SV, Noack T, Kappetein AP, Serruys PW, Mohr FW, Morice MC, Mack MJ, Ståhle LEGE, Verberkmoes NJ, Holmes DR, Head SJ. Long-term survival after coronary bypass surgery with multiple versus single arterial grafts. Eur J Cardiothorac Surg. 2021 Oct 07; doi: 10.1093/ejcts/ezab392. Epub 2021 Oct 07. PMID: 34618017.
Copy Download .nbib Format: NLM
Comparison of a Complete Percutaneous versus Surgical Approach to Aortic Valve Replacement and Revascularization in Patients at Intermediate Surgical Risk: Results from the Randomized SURTAVI Trial.

Circulation

Søndergaard L, Popma JJ, Reardon MJ, Van Mieghem NM, Deeb GM, Kodali S, George I, Williams MR, Yakubov SJ, Kappetein AP, Serruys PW, Grube E, Schiltgen MB, Chang Y, Engstrøm T.
PMID: 31476897
Circulation. 2019 Sep 03; doi: 10.1161/CIRCULATIONAHA.118.039564. Epub 2019 Sep 03.

BACKGROUND: For patients with severe aortic stenosis (AS) and coronary artery disease (CAD), the completely percutaneous approach to aortic valve replacement and revascularization has not been compared to the standard surgical approach.METHODS: The prospective SURTAVI trial enrolled intermediate-risk patients...

Cite
Søndergaard L, Popma JJ, Reardon MJ, et al. Comparison of a Complete Percutaneous versus Surgical Approach to Aortic Valve Replacement and Revascularization in Patients at Intermediate Surgical Risk: Results from the Randomized SURTAVI Trial. Circulation. 2019;doi: 10.1161/CIRCULATIONAHA.118.039564.
Søndergaard, L., Popma, J. J., Reardon, M. J., Van Mieghem, N. M., Deeb, G. M., Kodali, S., George, I., Williams, M. R., Yakubov, S. J., Kappetein, A. P., Serruys, P. W., Grube, E., Schiltgen, M. B., Chang, Y., Engstrøm, T. (2019). Comparison of a Complete Percutaneous versus Surgical Approach to Aortic Valve Replacement and Revascularization in Patients at Intermediate Surgical Risk: Results from the Randomized SURTAVI Trial. Circulation, . https://doi.org/10.1161/CIRCULATIONAHA.118.039564
Søndergaard, Lars, et al. "Comparison of a Complete Percutaneous versus Surgical Approach to Aortic Valve Replacement and Revascularization in Patients at Intermediate Surgical Risk: Results from the Randomized SURTAVI Trial." Circulation vol. (2019). doi: https://doi.org/10.1161/CIRCULATIONAHA.118.039564
Søndergaard L, Popma JJ, Reardon MJ, Van Mieghem NM, Deeb GM, Kodali S, George I, Williams MR, Yakubov SJ, Kappetein AP, Serruys PW, Grube E, Schiltgen MB, Chang Y, Engstrøm T. Comparison of a Complete Percutaneous versus Surgical Approach to Aortic Valve Replacement and Revascularization in Patients at Intermediate Surgical Risk: Results from the Randomized SURTAVI Trial. Circulation. 2019 Sep 03; doi: 10.1161/CIRCULATIONAHA.118.039564. Epub 2019 Sep 03. PMID: 31476897.
Copy Download .nbib Format: NLM
Antithrombotic therapy and bleeding events after aortic valve replacement with a novel bioprosthesis.

The Journal of thoracic and cardiovascular surgery

Klautz RJM, Vriesendorp MD, Dagenais F, Labrousse L, Bapat V, Moront MG, Misfeld M, Gearhart E, Kappetein AP, Sabik JF.
PMID: 31864696
J Thorac Cardiovasc Surg. 2019 Nov 02; doi: 10.1016/j.jtcvs.2019.10.095. Epub 2019 Nov 02.

OBJECTIVE: Several recent-generation surgical tissue valves have been found to have bleeding rates exceeding rates recommended by regulatory bodies. We explored bleeding events using data from the Pericardial Surgical Aortic Valve Replacement (PERIGON) Pivotal Trial for the Avalus valve...

Cite
Klautz RJM, Vriesendorp MD, Dagenais F, et al. Antithrombotic therapy and bleeding events after aortic valve replacement with a novel bioprosthesis. J Thorac Cardiovasc Surg. 2019;doi: 10.1016/j.jtcvs.2019.10.095.
Klautz, R. J. M., Vriesendorp, M. D., Dagenais, F., Labrousse, L., Bapat, V., Moront, M. G., Misfeld, M., Gearhart, E., Kappetein, A. P., & Sabik, J. F. (2019). Antithrombotic therapy and bleeding events after aortic valve replacement with a novel bioprosthesis. The Journal of thoracic and cardiovascular surgery, . https://doi.org/10.1016/j.jtcvs.2019.10.095
Klautz, Robert J M, et al. "Antithrombotic therapy and bleeding events after aortic valve replacement with a novel bioprosthesis." The Journal of thoracic and cardiovascular surgery vol. (2019). doi: https://doi.org/10.1016/j.jtcvs.2019.10.095
Klautz RJM, Vriesendorp MD, Dagenais F, Labrousse L, Bapat V, Moront MG, Misfeld M, Gearhart E, Kappetein AP, Sabik JF. Antithrombotic therapy and bleeding events after aortic valve replacement with a novel bioprosthesis. J Thorac Cardiovasc Surg. 2019 Nov 02; doi: 10.1016/j.jtcvs.2019.10.095. Epub 2019 Nov 02. PMID: 31864696.
Copy Download .nbib Format: NLM
Adoption of Transcatheter Aortic Valve Implantation in Western Europe.

Interventional cardiology (London, England)

Mylotte D, Osnabrugge RL, Martucci G, Lange R, Kappetein AP, Piazza N.
PMID: 29588776
Interv Cardiol. 2014 Mar;9(1):37-40. doi: 10.15420/icr.2011.9.1.37.

Transcatheter aortic valve implantation (TAVI) is a novel therapeutic option for patients with severe symptomatic aortic stenosis (AS) at excessive or high surgical risk for conventional surgical aortic valve replacement. First commercialised in Europe in 2007, TAVI growth has...

Cite
Mylotte D, Osnabrugge RL, Martucci G, et al. Adoption of Transcatheter Aortic Valve Implantation in Western Europe. Interv Cardiol. 2014;9(1):37-40doi: 10.15420/icr.2011.9.1.37.
Mylotte, D., Osnabrugge, R. L., Martucci, G., Lange, R., Kappetein, A. P., & Piazza, N. (2014). Adoption of Transcatheter Aortic Valve Implantation in Western Europe. Interventional cardiology (London, England), 9(1), 37-40. https://doi.org/10.15420/icr.2011.9.1.37
Mylotte, Darren, et al. "Adoption of Transcatheter Aortic Valve Implantation in Western Europe." Interventional cardiology (London, England) vol. 9,1 (2014): 37-40. doi: https://doi.org/10.15420/icr.2011.9.1.37
Mylotte D, Osnabrugge RL, Martucci G, Lange R, Kappetein AP, Piazza N. Adoption of Transcatheter Aortic Valve Implantation in Western Europe. Interv Cardiol. 2014 Mar;9(1):37-40. doi: 10.15420/icr.2011.9.1.37. PMID: 29588776; PMCID: PMC5808721.
Copy Download .nbib Format: NLM
Quality of life among patients with severe aortic stenosis.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

van Geldorp MW, Heuvelman HJ, Kappetein AP, Busschbach JJ, Cohen DJ, Takkenberg JJ, Bogers AJ.
PMID: 23229811
Neth Heart J. 2013 Jan;21(1):21-7. doi: 10.1007/s12471-012-0364-9.

BACKGROUND: The disease burden of patients with severe aortic stenosis is not often explored, while the incidence is increasing and many patients who have an indication for aortic valve replacement are not referred for surgery. We studied the quality...

Cite
van Geldorp MW, Heuvelman HJ, Kappetein AP, et al. Quality of life among patients with severe aortic stenosis. Neth Heart J. 2013;21(1):21-7doi: 10.1007/s12471-012-0364-9.
van Geldorp, M. W., Heuvelman, H. J., Kappetein, A. P., Busschbach, J. J., Cohen, D. J., Takkenberg, J. J., & Bogers, A. J. (2013). Quality of life among patients with severe aortic stenosis. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 21(1), 21-7. https://doi.org/10.1007/s12471-012-0364-9
van Geldorp, M W A, et al. "Quality of life among patients with severe aortic stenosis." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 21,1 (2013): 21-7. doi: https://doi.org/10.1007/s12471-012-0364-9
van Geldorp MW, Heuvelman HJ, Kappetein AP, Busschbach JJ, Cohen DJ, Takkenberg JJ, Bogers AJ. Quality of life among patients with severe aortic stenosis. Neth Heart J. 2013 Jan;21(1):21-7. doi: 10.1007/s12471-012-0364-9. PMID: 23229811; PMCID: PMC3528854.
Copy Download .nbib Format: NLM
The effect of aortic valve replacement on quality of life in symptomatic patients with severe aortic stenosis.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

van Geldorp MW, Heuvelman HJ, Kappetein AP, Busschbach JJ, Takkenberg JJ, Bogers AJ.
PMID: 23239448
Neth Heart J. 2013 Jan;21(1):28-35. doi: 10.1007/s12471-012-0362-y.

BACKGROUND: Although symptomatic patients with severe aortic stenosis have a high disease burden and guidelines recommend aortic valve replacement, many are treated conservatively. This study describes to what extent quality of life is changed by aortic valve replacement relative...

Cite
van Geldorp MW, Heuvelman HJ, Kappetein AP, et al. The effect of aortic valve replacement on quality of life in symptomatic patients with severe aortic stenosis. Neth Heart J. 2013;21(1):28-35doi: 10.1007/s12471-012-0362-y.
van Geldorp, M. W., Heuvelman, H. J., Kappetein, A. P., Busschbach, J. J., Takkenberg, J. J., & Bogers, A. J. (2013). The effect of aortic valve replacement on quality of life in symptomatic patients with severe aortic stenosis. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 21(1), 28-35. https://doi.org/10.1007/s12471-012-0362-y
van Geldorp, M W A, et al. "The effect of aortic valve replacement on quality of life in symptomatic patients with severe aortic stenosis." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 21,1 (2013): 28-35. doi: https://doi.org/10.1007/s12471-012-0362-y
van Geldorp MW, Heuvelman HJ, Kappetein AP, Busschbach JJ, Takkenberg JJ, Bogers AJ. The effect of aortic valve replacement on quality of life in symptomatic patients with severe aortic stenosis. Neth Heart J. 2013 Jan;21(1):28-35. doi: 10.1007/s12471-012-0362-y. PMID: 23239448; PMCID: PMC3528853.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 44 entries